查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
寡核苷酸合成市场：趋势、机会与竞争分析 [2023-2028]
市场调查报告书
商品编码
1341989

寡核苷酸合成市场：趋势、机会与竞争分析 [2023-2028]

Oligonucleotide Synthesis Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

寡核苷酸合成市场趋势及预测

预计到 2028 年，全球寡核苷酸合成市场将达到 158 亿美元，2023 年至 2028 年年复合成长率为 16.1%。该市场的主要促进因素是增加政府对製药和生物技术领域的资助和研究投资、增加合成寡核苷酸在分子诊断和临床应用中的利用率，以及全球癌症和遗传疾病发病率的增加。全球寡核苷酸合成市场的未来前景广阔，为医院、製药和生物技术公司、诊断实验室、CRO 和 CMO 以及学术研究机构提供了商机。

寡核苷酸合成市场洞察

  • Lucintel 预测，由于基因组研究（包括基因表现分析和基因测试）的日益普及，以及能够同时分析各种临床样本的生物晶片（DNA 晶片）的出现，寡核苷酸在预测期内将具有最高的增长率。预测我们将实现这一目标。
  • 在这个市场中，已开发国家的大学和学术研究机构正在与私人投资者共同或在政府支持下对基因组研究进行巨额投资，基因组研究正在积极开展，学术研究机构仍将是最大的细分市场。
  • 由于慢性病罹患率不断上升以及该地区有许多公司和研究机构，预计北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些，由于材料或产品替代导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球寡核苷酸合成市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2017-2028年市场趋势及预测分析

  • 宏观经济趋势（2017-2022）与预测（2023-2028）
  • 全球寡核苷酸合成市场趋势（2017-2022）与预测（2023-2028）
  • 全球寡核苷酸合成市场（按产品）
    • 寡核苷酸
    • 设备/合成器
    • 试剂
    • 服务
    • 精製
  • 全球寡核苷酸合成市场按应用
    • PCR引子
    • PCR 检测和麵板
    • 顺序
    • DNA微阵列
    • 萤光原位杂交（FISH）
  • 按最终用途行业分類的全球寡核苷酸合成市场
    • 医院
    • 製药和生物技术公司
    • 诊断实验室
    • 合约研究官（CRO）和首席行销长（CMO）
    • 学术研究所

第4章2017-2028年分地区市场趋势及预测分析

  • 全球寡核苷酸合成市场区域分布
  • 北美寡核苷酸合成市场
  • 欧洲寡核苷酸合成市场
  • 亚太寡核苷酸合成市场
  • 其他区域性寡核苷酸合成市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球寡核苷酸合成市场成长机会（按产品）
    • 全球寡核苷酸合成市场成长机会（按应用）
    • 最终用途产业的全球寡核苷酸合成市场成长机会
    • 全球寡核苷酸合成市场按地区成长机会
  • 全球寡核苷酸合成市场的新趋势
  • 战略分析
    • 新产品开发
    • 扩大全球寡核苷酸合成市场的产能
    • 全球寡核苷酸合成市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Thermo Fisher Scientific
  • GE Healthcare
  • Dharmacon
  • Agilent Technologies
  • Bio-synthesis
  • Kaneka Eurogentec
  • Integrated DNA Technologies
  • BioAutomation
  • Biolegio
  • Twist Bioscience
简介目录

Oligonucleotide Synthesis Market Trends and Forecast

The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes. The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028 with a CAGR of 16.1% from 2023 to 2028. The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.

A more than 150-page report is developed to help in your business decisions.

Oligonucleotide Synthesis Market by Segment

The study includes a forecast for the global oligonucleotide synthesis market by product, application, end use industry, and region, as follows:

Oligonucleotide Synthesis Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Oligonucleotides
  • Equipment/Synthesizer
  • Reagents
  • Services
  • Purification
  • Modification

Oligonucleotide Synthesis Market by Application [Shipment Analysis by Value from 2017 to 2028]:

  • PCR Primers
  • PCR Assays and Panels
  • Sequencing
  • DNA Microarrays
  • Fluorescence In Situ Hybridization (FISH)
  • Antisense Oligonucleotides
  • Others

Oligonucleotide Synthesis Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Hospitals
  • Pharmaceutical & Biotechnology Companies
  • Diagnostic Laboratories
  • CROs and CMOs
  • Academic Research Institutes

Oligonucleotide Synthesis Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Oligonucleotide Synthesis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, oligonucleotide synthesis companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the oligonucleotide synthesis companies profiled in this report include:

  • Thermo Fisher Scientific
  • GE Healthcare
  • Dharmacon
  • Agilent Technologies
  • Bio-synthesis
  • Kaneka Eurogentec
  • Integrated DNA Technologies
  • BioAutomation
  • Biolegio
  • Twist Bioscience

Oligonucleotide Synthesis Market Insights

  • Lucintel forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
  • Within this market, academic research institutes will remain the largest segment due to robust genomic research being conducted by universities and academic research institutes either in collaboration with private investors or with government support along with huge investments in the genomic research in developed countries.
  • North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.

Features of the Global Oligonucleotide Synthesis Market

  • Market Size Estimates: Oligonucleotide synthesis market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
  • Segmentation Analysis: Oligonucleotide synthesis market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).
  • Regional Analysis: Oligonucleotide synthesis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the Oligonucleotide Synthesis Market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the oligonucleotide synthesis market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q.1. What is the oligonucleotide synthesis market size?
  • Answer: The global oligonucleotide synthesis market is expected to reach an estimated $15.8 billion by 2028.
  • Q.2. What is the growth forecast for oligonucleotide synthesis market?
  • Answer: The global oligonucleotide synthesis market is expected to grow with a CAGR of 16.1% from 2023 to 2028.
  • Q.3. What are the major drivers influencing the growth of the oligonucleotide synthesis market?
  • Answer: The major drivers for this market are increasing government funding and research investments within the pharmaceutical and biotechnology sectors, rising utilization of synthesized oligonucleotides in molecular diagnostics and clinical applications, and rising incidence of cancer and genetic disorders globally.
  • Q4. What are the major segments for oligonucleotide synthesis market?
  • Answer: The future of the global oligonucleotide synthesis market looks promising with opportunities in hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes.
  • Q5. Who are the key oligonucleotide synthesis companies?
  • Answer: Some of the key oligonucleotide synthesis companies are as follows:
    • Thermo Fisher Scientific
    • GE Healthcare
    • Dharmacon
    • Agilent Technologies
    • Bio-Synthesis
    • Kaneka Eurogentec
    • Integrated DNA Technologies
    • BioAutomation
    • Biolegio
    • Twist Bioscience
  • Q6. Which oligonucleotide synthesis market segment will be the largest in future?
  • Answer: Lucintel forecasts that oligonucleotide will witness the highest growth over the forecast period due to the rising prevalence of genomic research endeavors, including gene expression analysis and genetic testing, along with the advent of biochips (DNA chips) enabling simultaneous analysis of various clinical samples.
  • Q7. In oligonucleotide synthesis market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to increasing incidence of chronic diseases and the substantial presence of numerous companies and research institutes in this region.
  • Q.8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the oligonucleotide synthesis market by product (oligonucleotides, equipment/synthesizer, reagents, services, purification, and modification), application (PCR primers, PCR assays and panels, sequencing, DNA microarrays, fluorescence in situ hybridization (FISH), antisense oligonucleotides, and others), end use industry (hospitals, pharmaceutical & biotechnology companies, diagnostic laboratories, CROs and CMOs, and academic research institutes), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Oligonucleotide Synthesis Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2: Global Oligonucleotide Synthesis Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Oligonucleotide Synthesis Market by Product
    • 3.3.1: Oligonucleotides
    • 3.3.2: Equipment/Synthesizer
    • 3.3.4: Reagents
    • 3.3.5: Services
    • 3.3.6: Purification
  • 3.4: Global Oligonucleotide Synthesis Market by Application
    • 3.4.1: PCR Primers
    • 3.4.2: PCR Assays and Panels
    • 3.4.3: Sequencing
    • 3.4.4: DNA Microarrays
    • 3.4.5: Fluorescence in Situ Hybridization (FISH)
  • 3.5: Global Oligonucleotide Synthesis Market by End Use Industry
    • 3.5.1: Hospitals
    • 3.5.2: Pharmaceutical & Biotechnology Companies
    • 3.5.3: Diagnostic Laboratories
    • 3.5.4: CROs and CMOs
    • 3.5.5: Academic Research Institutes

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Oligonucleotide Synthesis Market by Region
  • 4.2: North American Oligonucleotide Synthesis Market
    • 4.2.1: North American Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.2.2: North American Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.3: European Oligonucleotide Synthesis Market
    • 4.3.1: European Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.3.2: European Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.4: APAC Oligonucleotide Synthesis Market
    • 4.4.1: APAC Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.4.2: APAC Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes
  • 4.5: ROW Oligonucleotide Synthesis Market
    • 4.5.1: ROW Oligonucleotide Synthesis Market by Product: Oligonucleotide, Equipment/Synthesizer, Reagents, Services, Purification, and Modification
    • 4.5.2: ROW Oligonucleotide Synthesis Market by End Use Industry: Hospitals, Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CROs and CMOs, and Academic Research Institutes

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Product
    • 6.1.2: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Application
    • 6.1.3: Growth Opportunities for the Global Oligonucleotide Synthesis Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Oligonucleotide Synthesis Market by Region
  • 6.2: Emerging Trends in the Global Oligonucleotide Synthesis Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Oligonucleotide Synthesis Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Oligonucleotide Synthesis Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Thermo Fisher Scientific
  • 7.2: GE Healthcare
  • 7.3: Dharmacon
  • 7.4: Agilent Technologies
  • 7.5: Bio-synthesis
  • 7.6: Kaneka Eurogentec
  • 7.7: Integrated DNA Technologies
  • 7.8: BioAutomation
  • 7.9: Biolegio
  • 7.10: Twist Bioscience